XML 55 R46.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CONDENSED BALANCE SHEET (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets $ 62,315,000 $ 60,662,000
Total assets 97,595,000 98,329,000
Total liabilities 87,859,000 87,398,000
Total preferred stock and stockholders’ deficit 10,091,000 11,286,000
Total liabilities and stockholders’ deficit 97,595,000 98,329,000
Melt Pharmaceuticals, Inc. [Member]    
Current assets 9,025,000 11,278,000
Non-current assets 360,000
Total assets 9,385,000 11,278,000
Total liabilities 17,313,000 15,732,000
Total preferred stock and stockholders’ deficit (7,928,000) (4,454,000)
Total liabilities and stockholders’ deficit $ 9,385,000 $ 11,278,000